Singapore talking to AstraZeneca about vaccine
[SINGAPORE] Singapore's health authority said on Monday it was in talks with AstraZeneca about its coronavirus vaccine and had sought more information from Sinovac Biotech prior to using it vaccine for its immunisation drive.
Many Asian countries are now accelerating the rollout of AstraZeneca's vaccine despite a brief scare in Europe, where many countries temporarily halted its deployment over reports that it was linked to blood clotting.
"The Health Sciences Authority (HSA) had been in communication with various companies including AstraZeneca on their submission plans for Covid-19 vaccines," the authority said in a statement, adding that all vaccines are rigorously evaluated.
Singapore has so far been using the Pfizer-BioNTech and Moderna Covid-19 vaccines, with 792,423 doses administered so far.
Singapore took delivery of unspecified number of doses of Sinovac's CoronaVac last month, but has yet to grant it emergency use authorisation.
The health authority said it had requested more information from Sinovac "to assess if it can meet the required standards for quality, safety and efficacy", without elaborating.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
As more Asean states turn to Russia for fuel, will Moscow boost its influence in the region?
Succession in Singapore: Is the era of family empires coming to an end?
‘We’re not a bubble tea brand’: Chagee aims to double Asia-Pacific footprint to 600 stores by 2027